Company intelligence / Profile preview

Debut Biotech

San Diego, California, United Statesdebutbiotech.com ↗

Ownership: Private
Employees: ~81
Development stage: Preclinical

Overview

Debut Biotech develops proprietary cell-free biomanufacturing platforms enabling sustainable production of small and large molecules—primarily targeting the beauty, personal care, and wellness industries. The company leverages advanced continuous manufacturing approaches with a focus on sustainability. It has filed patents related to cell-free synthesis of complex bioactive compounds such as monoterpenes and opioids. There are no disclosed clinical results or pharmaceutical-stage assets.

Therapeutic areas: OtherDermatology
Modalities: Small moleculeslarge molecules (biocatalysis-based production)
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Debut Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Debut Biotech.

Explore the full profile